KETOL

Main information

  • Trade name:
  • KETOL ANTI-KETOGENIC AGENT
  • Pharmaceutical form:
  • ORAL SOLUTION/SUSPENSION
  • Units in package:
  • 2L, 5L, 20L
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • BAYER AUSTRALIA

Documents

Localization

  • Available in:
  • KETOL ANTI-KETOGENIC AGENT
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | SHEEP | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | EWE | HEIFER | H
  • Therapeutic area:
  • antiketogenic
  • Therapeutic indications:
  • CORTICOSTEROID | KETOSIS | ACETONAEMIA | ADVANCING PARTURITION | ALLERGIC REACTIONS | ANTIADRENAL SUPPRESSION | ANTI-INFLAMMATORY | ANTISHOCK | ARTHRITIS | BRONCHITIS | CATABOLIC COMPLICATIONS | CHRONIC BRONCHITIS | CORTICOSTEROIDS | CORTICOSTEROIDS AND RELATE | COUGHS | DERMATITIS | DERMATOLOGICAL DISORDERS | DERMATOSES | ECZEMA | ELEVATED KETONES | GLUCOGENIC STEROID | JOINT DISEASE | KETOSIS | LOCOMOTIVE DISEASES | MUSCULO SKELETAL INFLAMMAT | NON-CLINICAL KETOSIS | ORTHOPAEDIC | PARTURIENT UDDER OEDEMA | PARTURITION | PRURITIS | RESPIRATORY TRACT DISEASES | RHEUMATIC DISEASES | STRESS | TOXAEMIA | WATER RETENTION
  • Product summary:
  • An aid in the treatment of acetonaemia (ketosis) in cattle and pregnancy toxaemia in sheep.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36021/59309
  • Authorization date:
  • 19-03-2014
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Bayer

Australia

(Animal

Health)

Product

Name:

Keto

Anti-Ketogenic

Agent

Version:

Date

Change:

March

2014

Page

Text above this line is not included

the actual label

ANIMAL TREATMENT

ONLY

Ketal™

Anti-Ketogenic

Agent

Active Constituents:

Approved

{drumMuster logo)

PROPYLENE

GLYCOL832g/L,

CHOLINE

CHLORIDE

20.6g/L,

COBALT

(II)

SULPHATE

l.lOg/L

aid in the

treatment

acetonaemia (ketosis) in cattle and pregnancy toxaemia in sheep.

DIRECTIONS

DOSAGE

AND ADMINISTRATION

For oral use only.

[SL,

20L]

Cattle:

250mL morning and evening

2 days. For the next

days reduce

125mL

morning

and evening.

Sheep

125mL daily. Treatment

given

10 days.

WITHHOLDING

PERIODS

MEAT:

ZERO

days.

MILK:

ZERO

(0) days.

TRADE

ADVICE

EXPORT

SLAUGHTER

INTERVAL

(ESI):

Zero

days

FIRST

poisoning 'occurs contact a doctor,

the Poisons

Information

Centre. Phone Australia

131126.

Bayer

Australia

(Animal Health)

Product

Name:

Ketal

Anti-Ketogenic

Agent

Version: 3

Date

Change:

March

2014

Page

2 of 2

Text

above

this

line

is

not

included

in

the

actual

label

DISPOSAL

This container

recycled

if it

clean, dry, free

visible residues

the drumMUSTER

logo visible. Triple

pressure rinse container for disposal. Dispose

rinsate or any undiluted

chemical according to State legislative requirements.

Wash

outside

the container

theca

Store cleaned container

a sheltered place

with

removed.

It

will then

acceptable for

recycling at any drumMUSTER collection or similar container management program site.

should

replaced but may

taken separately.

STORAGE

Store below

30"C

(Room temperature). Protect from light.

KETOL"'

is

a trademark

of

Bayer AG, Leverkusen, Germany.

APVMA

Approval No.

36021/59309

Batch

Expiry Date.

18-12-2018

Enovachem Pharmaceuticals Issues Voluntary Nationwide Recall of Dyural-40 and Dyural-80 Convenience Kits Containing Recalled Sodium Chloride Injection, USP, 0.9% Due to Latex Hazard

Enovachem Pharmaceuticals Issues Voluntary Nationwide Recall of Dyural-40 and Dyural-80 Convenience Kits Containing Recalled Sodium Chloride Injection, USP, 0.9% Due to Latex Hazard

Torrance, CA, Asclemed USA Inc is voluntarily recalling 20 lots of Dyural-40 and 61 lots of Dyural-80, to the user level. The products include recalled Sodium Chloride, USP, 0.9% manufactured by Fresenius Kabi, which has been recalled due to product labeling incorrectly stating stoppers do not contain latex.

FDA - U.S. Food and Drug Administration

21-11-2018

Fresenius Kabi Issues Voluntary Nationwide Recall of Sodium Chloride Injection, USP, 0.9% Due to Product Labeling Incorrectly Stating Stoppers Do Not Contain Latex

Fresenius Kabi Issues Voluntary Nationwide Recall of Sodium Chloride Injection, USP, 0.9% Due to Product Labeling Incorrectly Stating Stoppers Do Not Contain Latex

Fresenius Kabi USA is voluntarily recalling 163 lots of Sodium Chloride Injection, USP, 0.9%, 10 mL fill in a 10 mL vial and Sodium Chloride Injection, USP, 0.9%, 20 mL fill in a 20 mL vial to the user level. The product insert states that stoppers for both the 10mL and the 20mL vials do not contain natural rubber latex; the tray label for the two vial sizes and the vial label for the 20mL vial also state that the stoppers do not contain latex. The product is being recalled because the stoppers contain n...

FDA - U.S. Food and Drug Administration

There are no news related to this product.